View in EDS

Outcomes of Patients With IDH1-Mutated Myeloid Neoplasms Treated With Olutasidenib.

Saved in:
Bibliographic Details
Title: Outcomes of Patients With IDH1-Mutated Myeloid Neoplasms Treated With Olutasidenib.
Authors: Chien KS; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Loghavi S; Departments of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX., Sasaki K; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., McCue D; Departments of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX., Daver NG; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Kadia TM; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Ravandi F; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Short NJ; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Issa GC; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Montalban-Bravo G; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Haddad FG; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Hammond DE; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Swaminathan M; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Bazinet A; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Bataller A; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Bouligny I; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Pierce SA; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Garcia-Manero G; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Kantarjian HM; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., DiNardo CD; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address: cdinardo@mdanderson.org.
Source: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2026 Feb; Vol. 26 (2), pp. e223-e228.e3. Date of Electronic Publication: 2025 Dec 10.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41469316
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Outcomes of Patients With IDH1-Mutated Myeloid Neoplasms Treated With Olutasidenib.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Chien+KS%22">Chien KS</searchLink>; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Loghavi+S%22">Loghavi S</searchLink>; Departments of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Sasaki+K%22">Sasaki K</searchLink>; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22McCue+D%22">McCue D</searchLink>; Departments of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Daver+NG%22">Daver NG</searchLink>; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Kadia+TM%22">Kadia TM</searchLink>; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Ravandi+F%22">Ravandi F</searchLink>; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Short+NJ%22">Short NJ</searchLink>; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Issa+GC%22">Issa GC</searchLink>; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Montalban-Bravo+G%22">Montalban-Bravo G</searchLink>; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Haddad+FG%22">Haddad FG</searchLink>; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Hammond+DE%22">Hammond DE</searchLink>; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Swaminathan+M%22">Swaminathan M</searchLink>; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Bazinet+A%22">Bazinet A</searchLink>; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Bataller+A%22">Bataller A</searchLink>; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Bouligny+I%22">Bouligny I</searchLink>; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Pierce+SA%22">Pierce SA</searchLink>; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Garcia-Manero+G%22">Garcia-Manero G</searchLink>; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Kantarjian+HM%22">Kantarjian HM</searchLink>; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22DiNardo+CD%22">DiNardo CD</searchLink>; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address: cdinardo@mdanderson.org.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101525386%22">Clinical lymphoma, myeloma & leukemia</searchLink> [Clin Lymphoma Myeloma Leuk] 2026 Feb; Vol. 26 (2), pp. e223-e228.e3. <i>Date of Electronic Publication: </i>2025 Dec 10.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101525386 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2152-2669 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221522669%22">21522669 </searchLink><i>NLM ISO Abbreviation: </i>Clin Lymphoma Myeloma Leuk <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41469316
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.clml.2025.12.001
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e223
    Titles:
      – TitleFull: Outcomes of Patients With IDH1-Mutated Myeloid Neoplasms Treated With Olutasidenib.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Chien KS
      – PersonEntity:
          Name:
            NameFull: Loghavi S
      – PersonEntity:
          Name:
            NameFull: Sasaki K
      – PersonEntity:
          Name:
            NameFull: McCue D
      – PersonEntity:
          Name:
            NameFull: Daver NG
      – PersonEntity:
          Name:
            NameFull: Kadia TM
      – PersonEntity:
          Name:
            NameFull: Ravandi F
      – PersonEntity:
          Name:
            NameFull: Short NJ
      – PersonEntity:
          Name:
            NameFull: Issa GC
      – PersonEntity:
          Name:
            NameFull: Montalban-Bravo G
      – PersonEntity:
          Name:
            NameFull: Haddad FG
      – PersonEntity:
          Name:
            NameFull: Hammond DE
      – PersonEntity:
          Name:
            NameFull: Swaminathan M
      – PersonEntity:
          Name:
            NameFull: Bazinet A
      – PersonEntity:
          Name:
            NameFull: Bataller A
      – PersonEntity:
          Name:
            NameFull: Bouligny I
      – PersonEntity:
          Name:
            NameFull: Pierce SA
      – PersonEntity:
          Name:
            NameFull: Garcia-Manero G
      – PersonEntity:
          Name:
            NameFull: Kantarjian HM
      – PersonEntity:
          Name:
            NameFull: DiNardo CD
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: 2026 Feb
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2152-2669
          Numbering:
            – Type: volume
              Value: 26
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Clinical lymphoma, myeloma & leukemia
              Type: main
ResultId 1